The Hong Kong Market's "Leftover" Bin: Who's Faking It and Who's Real?Global Report·Aug 19 at 04:44 AM01951+3.96%018750.00%
Hong Kong Niche Plays: Tech Upgrades and Fertility Turnarounds to WatchGlobal Report·Aug 19 at 04:42 AM01951+3.96%01187-0.19%
Divergent Signals from Hong Kong's Niche Sectors Highlight an Uneven RecoveryGlobal Report·Aug 11 at 04:43 AM01187-0.19%01770-8.22%
The Hong Kong Unbundling: Value Chains and the Niche Supplier OpportunityGlobal Report·Aug 6 at 04:15 AM01187-0.19%02522-1.41%
Cofoe Medical files HKEX next-day disclosure return on share repurchase for cancellationPUBT·Jul 28 at 04:50 AM01187-0.19%301087-4.11%
Hong Kong Mid-Caps Drive Summer Dealmaking Amid USD 2.3 Billion Bio-Licensing and Stock BuybacksGlobal Report·Jul 22 at 04:18 AM03692-1.78%01187-0.19%
The Strategic Divergence: When Real Estate Pivots to AI and Legacy Brands Seek New MoatsGlobal Report·Jul 15 at 04:14 AM01800+0.14%01798+1.72%
Hong Kong Healthcare and Industrials: RemeGen Advances as L.K. Tech Pivots to AI InfrastructureGlobal Report·Jul 9 at 09:02 PM09995-1.25%01187-0.19%
Pivots, Pitfalls, and the AI Mirage: Navigating Hong Kong's Fragmented 2026 MarketGlobal Report·Jul 9 at 05:03 AM03288-0.50%02338+4.11%
Cofoe Medical Technology Co. Ltd. Class H (1187) Receives a Buy from Exane BNP Paribasbusinessinsider·Jun 25 at 01:50 AM01187-0.19%
Brief News: COFOE MEDICAL's first listing fell nearly 6% in half a dayBambooWorks·May 6 at 12:31 AM01187-0.19%
COFOE passes the listing hearing: annual revenue of 3.4 billion, profit of 370 million, and the Zhang Min couple controls 54% of the equity雷帝触网·Apr 11 at 06:40 AM01187-0.19%301087-4.11%
Cofe Medical rushes to the Hong Kong stock market: annual revenue of 3.4 billion, profit of 370 million has obtained IPO filing雷帝触网·Mar 16 at 07:55 PM01187-0.19%
